Contineum Therapeutics Insider Trades

CTNM

Track insider trading activity from Contineum Therapeutics executives and directors. See which insiders are buying and selling CTNM stock.

Trades Last 12 Months

CTNM Price

All Insider Trades for Contineum Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lorrain Daniel S. Chief Scientific Officer
Holding Value $1.97M 135,227 shares
Last Trade
Jul 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$386 25 shares
$15.45
$14.57
Stengone Carmine N. CEO And President
Holding Value $287k 19,717 shares
Last Trade
Jul 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.1k 2,500 shares
$15.65
$14.57
Watkins Tim CMO & Head Of Development
Holding Value $3.47M 238,334 shares
Last Trade
Jun 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 10,833 shares
$16.39
$14.57
Boyce Sarah Director
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Brady Todd R. Director
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Ignelzi Troy A. Director
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Ware Olivia C Director
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
Healy John Stephen General Counsel And Corp Sec
Holding Value $3.01M 206,411 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 206,411 shares
$14.26
$14.57
Slover Peter T Chief Financial Officer
Holding Value $2.8M 192,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.74M 192,000 shares
$14.26
$14.57
Huhn Stephen L. CMO & Sr Vp, Clinical Dev.
Holding Value $1.6M 110,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 110,000 shares
$9.79
$14.57

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up